WW+E Celebrates Banner Year of High Stakes Trial Wins By Next Generation Of Trial Lawyers

wwe Homepage news, News, News

WASHINGTON – Wilkinson Walsh + Eskovitz is racing into its fourth year after notching a series of high-profile victories, led by a large and diverse group of partners. In 2018, all of WW+E’s partners participated in trials and case-dispositive hearings, and several other attorneys achieved significant on-their-feet experience, including through pro bono cases. The firm earned repeated recognition for the depth and successes of its bench and added a new crop of talented litigators to its roster. WW+E won three trials in 2018, each of which was first-chaired by a different partner: On April 27, 2018, WW+E, led by Brian Stekloff, Jeremy Barber, and Lori McGill, won a unanimous defense verdict for Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals in Russell v. Janssen Pharmaceuticals, Inc., the second state-court Xarelto bellwether trial in the Pennsylvania Court of Common Pleas. On May 21, 2018, WW+E, led by Kosta Stojilkovic and Rakesh …

Experienced Litigator Julie Rubenstein Promoted To WW+E Counsel

wwe Homepage news, News, News

WASHINGTON– Wilkinson Walsh + Eskovitz today announced that Julie Rubenstein has been promoted to Counsel effective January 1, 2019. Since joining WW+E as an associate, Rubenstein has used her breadth of experience representing corporate and individual clients to secure major victories for WW+E’s clients. Rubenstein most recently helped the NCAA obtain a defense jury verdict in a month-long defamation trial in Todd McNair v. NCAA. She led oral arguments on several key issues, including jury instructions, and she successfully defended against Plaintiff’s motion to compel. Her promotion is a testament to the firm’s investment in its next generation of leading attorneys and its emphasis on getting those attorneys into the courtroom. “Wilkinson Walsh + Eskovitz is a powerhouse firm because all attorneys – associates, counsel, and partners – are encouraged and empowered to contribute meaningfully to all aspects of our trial work,”said Ms. Rubenstein. “I am honored to work at …